ARCHIVES

IOM Committee Will Probe Duke Scandal Together With Other “Omics” Case Studies

This article is from The Cancer Letter archive.

Vol. 37 No. 01 | January 7, 2011

Download PDF Visit The Full Archive

Related Articles

Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer

April 24, 2009

Clinical Sciences Director Liu To Head Singapore Program.

January 12, 2001

IG Report Clears Shubik Of Conflict Of Interest Change

October 6, 1978

Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study

December 26, 2014

Funding Opportunities

September 27, 2002

Ibrutinib Demonstrates Responses In Large B-Cell Lymphomas

April 27, 2012